Federal health programs contributing to the control of breast cancer
β Scribed by Stanley W. Olson
- Publisher
- John Wiley and Sons
- Year
- 1969
- Tongue
- English
- Weight
- 431 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
T grams contributing to the control of breast cancer. Outstanding among these is the National Cancer Institute with its intramural and extramural programs for research and research training, its sponsorship of clinical research activities, its Committee for Radiation Therapy Studies, its Task Force on Breast Cancer, and other well-known work. Dr. Kenneth M. Endicott, Director of the Institute, and his staff, have contributed leadership and important support to many of the current efforts directed toward the control of breast cancer. T h e Cancer Control Program, headed by Dr. William L. Ross, is an outgrowth of the work of the National Cancer Institute. It was established as a separate program in 1961. T h e mission of the program is to adapt for wider community utilization, new knowledge about cancer which emerges from research efforts and clinical experience. RECENT ADMINISTRATIVE CHANGES Within the past several years, the Cancer Control Program has been subject to a number of administrative reorganizations. First located in the Chronic Disease Division of the Bureau of State Services the Cancer Control Program was later scheduled to become one of the components of a new Bureau of Community Health, but this plan was never approved by the Congress. Despite these organizational disputes, the Cancer Control Program grew, and in Fiscal Year 1966, $15 million in p a n t funds were allocated, which were divided about equally between service and training projects. About the same time, 2 other major programs were evolving concurrently which had an important effect on the Cancer Control Program. These were programs concerned
π SIMILAR VOLUMES
Overexpression of gp185 erbB-2 has been associated with reduced survival in breast-cancer patients. Our earlier results, now confirmed in a larger cohort of patients ( ), evidenced that the HLA-A2 allele may participate in the modulation of the erbB-2 tumor phenotype in vivo. In the present study, w
## Abstract ## Background The ageβadjusted incidence rate of breast cancer has increased for Israeli women. Our aim was to explore the hypothesis that occupational exposures are important risk factors, taking into consideration main known risk factors. ## Methods The study population included 32
## Background: The national cancer data base (ncdb) is an information resource and program evaluation tool of the american college of surgeons commission on cancer and the american cancer society that uses a hospital-based cancer reporting system. the surveillance, epidemiology, and end results (se